Top 10 Companies in the Global Cloperastine Hydrochloride Market (2026): Market Leaders Powering Global Respiratory Care

MARKET INSIGHTS

Global Cloperastine Hydrochloride Market was valued at USD 19.7 million in 2025. The market is projected to grow from USD 20.3 million in 2026 to USD 40.1 million by 2034, exhibiting a CAGR of 8.2% during the forecast period.

The USA market for Cloperastine Hydrochloride is estimated to increase from USD 4.6 million in 2025 to reach USD 8.0 million by 2034, at a CAGR of 7.8% during the forecast period. The China market for Cloperastine Hydrochloride is estimated to increase from USD 6.2 million in 2025 to reach USD 12.5 million by 2034, at a CAGR of 10.5% during the forecast period. The Europe market for Cloperastine Hydrochloride is estimated to increase from USD 3.8 million in 2025 to reach USD 6.7 million by 2034, at a CAGR of 8.3% during the forecast period.

Cloperastine Hydrochloride is a centrally acting antitussive agent with antihistaminic properties, primarily used to treat dry, non-productive cough associated with respiratory conditions. This synthetic compound, identified by CAS number 14984-68-0, works by inhibiting the cough reflex in the brainstem while also providing mild sedative effects. It is commonly formulated into oral syrups, tablets, or solutions for pharmaceutical use, and is valued for its non-narcotic profile compared to opioid-based alternatives.

The market is experiencing steady growth driven by the rising prevalence of respiratory disorders such as asthma, bronchitis, and COPD worldwide, fueled by urbanization, pollution, and post-pandemic awareness of airway health. Furthermore, the demand for effective, non-opioid cough suppressants is boosting adoption in both over-the-counter and prescription segments. Advancements in pharmaceutical intermediates and chemical synthesis technologies are enhancing purity and availability. Key players like TCI, Waterstone Technology, AlliChem, and 3B Scientific maintain diverse portfolios, focusing on high-purity grades (98% and 99%) for research and manufacturing. For instance, ongoing investments in production facilities by companies in Asia-Pacific are supporting expanded supply chains to meet global needs.

Global Cloperastine Hydrochloride Market – View in Detailed Research Report

Top 10 Companies in the Global Cloperastine Hydrochloride Market (2026)

1️⃣ TCI (Tokyo Chemical Industry Co., Ltd.)

Headquarters: Tokyo, Japan
Key Offering: High-purity Cloperastine Hydrochloride (98% and 99%) for pharmaceutical intermediates

TCI has been a pioneer in providing research-grade APIs for over four decades. Its state-of-the-art purification processes ensure batch-to-batch consistency, making it the preferred supplier for major pharmaceutical companies worldwide.

Sustainability & Growth Initiatives:

• Investment in green chemistry processes to reduce solvent waste
• Expansion of production capacity in China and India to meet growing demand
• Partnerships with leading CROs for custom synthesis projects

2️⃣ Waterstone Technology

Headquarters: San Diego, California, USA
Key Offering: Ultra-high purity (99%) Cloperastine Hydrochloride for research and manufacturing

Waterstone Technology specializes in delivering pharmaceutical-grade APIs with stringent quality controls, supporting both contract manufacturers and in-house production.

Sustainability & Growth Initiatives:

• Implementation of ISO 14001 environmental management systems
• Strategic collaborations with university research labs
• Development of scalable synthesis routes for cost efficiency

3️⃣ AlliChem

Headquarters: Los Angeles, California, USA
Key Offering: High-purity Cloperastine Hydrochloride and related antitussive APIs

AlliChem focuses on providing high-quality intermediates to the pharmaceutical and nutraceutical sectors, emphasizing rigorous testing and compliance with global regulatory standards.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources in manufacturing plants
• Participation in circular economy programs to recycle solvents
• Expansion of product portfolio to include combination therapy APIs

4️⃣ 3B Scientific

Headquarters: Beijing, China
Key Offering: Cloperastine Hydrochloride in 98% and 99% grades for pharmaceutical intermediates

3B Scientific serves the Asian market with high-volume production and offers customized purification services for global clients.

Sustainability & Growth Initiatives:

• Investment in advanced chromatographic purification systems
• Collaboration with local universities for R&D projects
• Expansion of distribution network across Southeast Asia

5️⃣ Nacalai Tesque

Headquarters: Kyoto, Japan
Key Offering: Research-grade Cloperastine Hydrochloride with 99% purity

Nacalai Tesque delivers high-quality APIs to academic and industrial research institutions, maintaining strict quality documentation.

Sustainability & Growth Initiatives:

• Implementation of zero-waste production practices
• Engagement in global sustainability certification programs
• Development of eco-friendly solvent systems

6️⃣ Advance Scientific & Chemical

Headquarters: Chicago, Illinois, USA
Key Offering: High-purity Cloperastine Hydrochloride for contract manufacturing

Advance Scientific & Chemical offers turnkey API manufacturing services, catering to both small and large pharmaceutical companies.

Sustainability & Growth Initiatives:

• ISO 9001 certification for quality management
• Investment in energy-efficient reactors
• Strategic alliances with global distributors

7️⃣ Fujifilm Wako Pure Chemical Corporation

Headquarters: Osaka, Japan
Key Offering: Cloperastine Hydrochloride (98% and 99%) for pharmaceutical research and manufacturing

As part of Fujifilm, Wako provides a comprehensive portfolio of high-purity chemicals, supporting both academic research and industrial production.

Sustainability & Growth Initiatives:

• Adoption of green chemistry principles across all facilities
• Participation in global chemical safety initiatives
• Expansion of production lines for emerging markets

8️⃣ BeiJing Hwrk Chemicals

Headquarters: Beijing, China
Key Offering: Cost-effective Cloperastine Hydrochloride (98%) for domestic and regional markets

BeiJing Hwrk focuses on providing high-quality APIs at competitive prices, leveraging local manufacturing efficiencies.

Sustainability & Growth Initiatives:

• Implementation of waste reduction programs
• Collaboration with local suppliers for raw material sourcing
• Expansion of export capacity to ASEAN markets

9️⃣ XiaoGan ShenYuan ChemPharm

Headquarters: Shanghai, China
Key Offering: Cloperastine Hydrochloride (98% and 99%) with rapid turnaround times

ShenYuan ChemPharm specializes in quick-turn synthesis and purification, catering to time-sensitive projects in pharma and biotech.

Sustainability & Growth Initiatives:

• Adoption of digital process monitoring for quality control
• Investments in renewable energy for production sites
• Strategic partnerships with regional distributors

🔟 Nanjing Sunlida Biological Technology

Headquarters: Nanjing, China
Key Offering: High-purity Cloperastine Hydrochloride for pharmaceutical intermediates and research

Sunlida provides reliable supply of APIs to both domestic and international clients, emphasizing consistency and traceability.

Sustainability & Growth Initiatives:

• Implementation of ISO 14001 environmental management
• Development of eco-friendly synthesis protocols
• Expansion of production capacity to meet rising demand

Download FREE Sample Report

Get a glimpse of the full research: Global Cloperastine Hydrochloride Market – View in Detailed Research Report

Get Full Report

Access the complete market analysis: Global Cloperastine Hydrochloride Market – View in Detailed Research Report

Outlook: The Future of Cloperastine Hydrochloride Market

The Cloperastine Hydrochloride market is poised for robust expansion, driven by the global push for non-opioid cough solutions, rising respiratory disease prevalence, and technological advancements in API manufacturing. The market is expected to maintain a steady CAGR of 8.2% through 2034, supported by increasing OTC availability and strategic investments in production capacity across Asia-Pacific.

Future Trends Shaping the Market

• High-purity (99%) API demand continues to rise, prompting investments in advanced purification technologies.
• Expansion of production facilities in emerging economies, particularly China and India, to meet global demand.
• Development of pediatric-friendly and sustained-release formulations to broaden therapeutic applications.
• Growth of e-commerce and telehealth platforms for OTC distribution, enhancing market reach.
• Strategic mergers and alliances among API suppliers to consolidate capabilities and expand global footprints.